(Q41375311)

English

High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial

scientific article published on 19 February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

phase III clinical trial

0 references

Adaptive radiation therapy

0 references

7

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

author name string

Almudena Zapatero

1

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Araceli Guerrero

2

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Xavier Maldonado

3

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Ana Alvarez

4

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Carmen Gonzalez San Segundo

5

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Maria Angeles Cabeza Rodríguez

6

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Agustí Pedro Olive

8

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Francesc Casas

9

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Ana Boladeras

10

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Carmen Martín de Vidales

11

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Maria Luisa Vazquez de la Torre

12

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Salvador Villà

13

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Aitor Perez de la Haza

14

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Felipe A Calvo

15

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

publication date

19 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

320-327

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of androgen suppression in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormone and radiotherapy versus hormone or radiotherapy alone for non-metastatic prostate cancer: a systematic review with meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy and short-term androgen deprivation for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The current role of androgen deprivation in patients undergoing dose-escalated external beam radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results after high-dose radiotherapy and adjuvant hormones in prostate cancer: how curable is high-risk disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation for high-risk prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate- and high-risk prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970045-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(15)70045-8

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41375311&oldid=2096728230"